verified SJR 0,351 · Q3 • database Scopus / SJR & Web of Science & DOAJ indexed

United Kingdom · Informa Healthcare

workspace_premium Q3 — Hematology lock Subscription · DOAJ

Pediatric Hematology and Oncology

Pediatric Hematology and Oncology is a journal indexed in SJR in Hematology and Oncology with an H index of 50. It has a price of 2395 €. It has an SJR impact factor of 0,351 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,351.

ISSN: 0888-0018

Publisher: Informa Healthcare

Category: Hematology

Indexation: verifiedScopus / SJR verifiedWeb of Science verifiedDOAJ

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,351 Q3

H-index 50

Acceptance rate pie_chart

32%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.395 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science DOAJ

SJR Impact

0,351

H-index

Docs (year)

Docs 3y

203

Total refs

1733

Cites 3y

220

Citable 3y

163

Cites/Doc 2y

1.03

Ref/Doc

28.41

Immediate OA

2395 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

CIRCUMCISION, HEMOPHILIA, AND BEING HEALTHY IN DEVELOPING COUNTRIES

VENO-OCCLUSIVE DISEASE OF THE LIVER ASSOCIATED WITH THIOPURINES IN A CHILD WITH ACUTE LYMPHOBLASTIC LEUKEMIA

ENHANCED VINCRISTINE NEUROTOXICITY FROM DRUG INTERACTIONS: Case Report and Review of Literature

ENCEPHALITIS AND MYOCARDITIS IN A CHILD WITH ACUTE LYMPHOBLASTIC LEUKEMIA: Role of Coxsackievirus B5?

EFFECT OF TWO-ROUND FICOLL-HYPAQUE DENSITY GRADIENT CENTRIFUGATION ON LYMPHOCYTE SUBSETS AND NATURAL KILLER ACTIVITY OF UMBILICAL CORD BLOOD MONONUCLEAR CELLS

EFFECT OF SHORT-COURSE, HIGH-DOSE STEROID THERAPY IN A CHILD WITH MYELODYSPLASTIC SYNDROME

Effect of Factor VIIIc Levels in Pediatric Stroke Patients

ECTOPIC CERVICAL THYMUS IN A 12-YEAR-OLD BOY: A Case Report

Double Allogeneic Peripheral Blood Stem Cell Transplantation in a 9-Year-Old Patient with Relapsed Acute Lymphoblastic Leukemia: Case Report

DNA PLOIDY AND PROGNOSIS OF NEUROBLASTOMA

DISSEMINATED MALIGNANT ECTOMESENCHYMOMA (MEM): Case Report and Review of the Literature

DEPLETED URANIUM--CAUSE FOR CONCERN OR JUST A GOOD STORY?

SHOW MORE ARTICLES

COMPARISON OF TROPISETRON AND GRANISETRON IN THE CONTROL OF NAUSEA AND VOMITING IN CHILDREN RECEIVING COMBINED CANCER CHEMOTHERAPY

A Fetal Case of Transient Abnormal Myelopoiesis with Severe Liver Failure in Down Syndrome: Prognostic Value of Serum Markers

CHILDHOOD NON-HODGKIN LYMPHOMA PRESENTING AS HEMOPHAGOCYTIC SYNDROME

CHILDHOOD CANCER SURVIVORS: A PRACTICAL GUIDE TO YOUR FUTURE, edited by Nancy Keene, Wendy Hobbie, and Kathy Ruccione

Childhood Cancer in Developing Countries

CHEMO- AND RADIOSENSITIVITY TESTING IN A PATIENT WITH ATAXIA TELANGIECTASIA AND HODGKIN DISEASE

Characterization of Bone Marrow Stromal Abnormalities in a Patient with Constitutional Trisomy 8 Mosaicism and Myelodysplastic Syndrome

Castleman Disease: A Case with Atypical Presentation

ASPECTS OF CHILDHOOD CANCER DURING THE BYZANTINE PERIOD

ANTIBIOTIC SEQUENTIAL THERAPY FOR FEBRILE NEUTROPENIA IN PEDIATRIC PATIENTS WITH MALIGNANCY

Amifostine as Differentiating Agent in Cord Blood and Bone Marrow Cultures from Children with Hematological Disorders

A VARIANT OF MYELOKATHEXIS WITH HYPOGAMMAGLOBULINEMIA: Lymphocytes as Well as Neutrophils may Reverse in Response to Infections

FAQs

Pediatric Hematology and Oncology has an SJR of 0,351 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is 2395 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Pediatric Hematology and Oncology is 32%.

Pediatric Hematology and Oncology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Pediatric Hematology and Oncology?

What is the APC / publication cost?

What is the acceptance rate?